Department of Health Systems Management, School of Public Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beersheba, Israel.
Isr J Health Policy Res. 2019 Sep 16;8(1):60. doi: 10.1186/s13584-019-0326-4.
Maximizing vaccination uptake is crucial in generating herd immunity and preventing infection incidence (Quach et al., Am J Infect Control 11:1017-23, 2013). Vaccination of healthcare personnel (HCP) against influenza is vital to influenza infection control in healthcare settings, given the consistent exposure of HCP to high-risk patients like: those with compromised immune systems, children, and the elderly (Johnson & Talbot, Curr Opin Infect Dis 24: 363-369, 2011). Influenza vaccination uptake among HCP remains suboptimal: in 2017-18, 47.6% of HCP who worked in settings where influenza vaccination was not mandatory were vaccinated against influenza in United States (Black et al., Morb Mortal Wkly Rep 67: 1050, 2018). Mandatory vaccination policies result in HCP influenza vaccination uptake rates substantially higher than opt-in influenza vaccination campaigns (94.8% vs. 47.6%) (Black et al., Morb Mortal Wkly Rep 67: 1050, 2018).
The Israel Journal of Health Policy Research has published articles focused on the issues of influenza vaccination (Yamin et al., Isr J Health Policy Res 3: 13, 2014), improving influenza vaccination coverage of HCP (Weber et al., Isr J Health Policy Res 5: 1-5, 2016), influenza vaccination motivators among HCP (Nutman and Yoeli, Isr J Health Policy Res 5: 52, 2016), legal imposition of vaccination (Kamin-Friedman, Isr J Health Policy Res 6:58, 2017), and mandatory vaccination (Gostin, Cell Biosci 8: 1-4, 2018). Each article explores factors influencing disease prevention from different angles within an Israeli context. This article attempts to fuse these topics by investigating how to apply aspects of American mandatory influenza vaccination policy targeted at HCP in an Israeli context.
Critical document analysis was conducted on relevant literature and policy discussing influenza prevention interventions among HCP within the United States. Mandatory vaccination policies were highlighted. A discussion of the professional responsibility of HCP to vaccinate against influenza serves as background. Case studies of hospitals in the United States that implemented mandatory vaccination policies for their employees are analyzed. The article concludes with analysis exploring how qualities of mandatory influenza vaccination policy of HCP could take shape in Israel, giving contextual limitations, urging Israeli health policy makers to reflect on lessons learned from the American case study.
Mandatory HCP influenza vaccination policies in comparison to non-mandatory interventions are most effective in obtaining maximum influenza vaccination uptake among HCP (Black et al., Morb Mortal Wkly Rep 67: 1050, 2018). Many HCP cite individual objections to influenza vaccination rooted in personal doubts and ethical concerns. The ethical responsibility of HCP to their patients and work environments to prevent and lower influenza infection incidence arguably overrules such individual objections. Mandatory HCP influenza vaccination policies are an effective method of maximizing HCP influenza vaccine uptake and minimizing the spread of the influenza virus within healthcare settings. Still, cultural, social and political sensitivity must be taken into consideration when implementing both full-on mandatory HCP influenza vaccination policies and/or aspects of mandatory policies, especially within an Israeli context.
最大限度地提高疫苗接种率对于产生群体免疫和预防感染发生率至关重要(Quach 等人,美国传染病控制杂志 11:1017-23,2013)。鉴于医护人员(HCP)持续接触高危患者,如免疫系统受损、儿童和老年人,因此对其进行流感疫苗接种对于医疗机构中的流感感染控制至关重要(Johnson 和 Talbot,当代传染病观点 24:363-369,2011)。HCP 对流感疫苗的接种率仍然不理想:2017-18 年,在美国,在未强制要求接种流感疫苗的环境中工作的 47.6%的 HCP 接种了流感疫苗(Black 等人,发病率和死亡率周报 67:1050,2018)。强制性疫苗接种政策可使 HCP 的流感疫苗接种率显著高于选择接种流感疫苗的疫苗接种活动(94.8% 与 47.6%)(Black 等人,发病率和死亡率周报 67:1050,2018)。
《以色列健康政策研究杂志》发表了一些聚焦流感疫苗接种问题的文章(Yamin 等人,以色列健康政策研究 3:13,2014)、提高 HCP 流感疫苗接种覆盖率(Weber 等人,以色列健康政策研究 5:1-5,2016)、HCP 接种流感疫苗的动机(Nutman 和 Yoeli,以色列健康政策研究 5:52,2016)、对疫苗接种的法律强制(Kamin-Friedman,以色列健康政策研究 6:58,2017)和强制性疫苗接种(Gostin,细胞生物科学 8:1-4,2018)。每篇文章都从以色列的角度探讨了不同角度影响疾病预防的因素。本文试图通过研究如何在美国将针对 HCP 的强制性流感疫苗接种政策的各个方面应用于以色列,来融合这些主题。
对美国 HCP 流感预防干预相关的相关文献和政策进行了批判性文献分析。强调了强制性疫苗接种政策。介绍了 HCP 有义务接种流感疫苗作为背景。分析了美国一些实施强制性疫苗接种政策的医院案例研究。本文最后探讨了如何在以色列形成 HCP 强制性流感疫苗接种政策的特点,并考虑到了背景限制,敦促以色列卫生政策制定者从美国案例研究中吸取教训。
与非强制性干预措施相比,强制性 HCP 流感疫苗接种政策在提高 HCP 接种率方面最有效(Black 等人,发病率和死亡率周报 67:1050,2018)。许多 HCP 引用个人对流感疫苗接种的反对意见,这些意见源于个人疑虑和道德担忧。HCP 对其患者和工作环境的道德责任,以预防和降低流感感染发生率,这可能超过了这种个人反对意见。强制性 HCP 流感疫苗接种政策是提高 HCP 流感疫苗接种率和降低医疗机构中流感病毒传播的有效方法。但是,在实施全面强制性 HCP 流感疫苗接种政策和/或强制性政策的各个方面时,特别是在以色列的背景下,必须考虑文化、社会和政治敏感性。